Thursday, 9 September

18.10 - 18.40

►Plenary lecture
History of Chemistry in University of Tartu
Prof. Enn Lust, University of Tartu

18.40 - 19.40

Welcome reception in the White Hall of the University of Tartu Museum and in the Old Anatomical Theatre

The Welcome Reception will take place both in the Old Anatomical Theatre and the White Hall of the University of Tartu Museum. More information will be provided to registered participants before the event.

Friday, 10 September

University of Tartu main building

8.15 - 8.20

►Opening
 Prof. Toomas Asser,  Rector of the University of Tartu

8.20 - 9.30

►Plenary lecture
Pharmacogenetics in psychopharmacology: approaches of individualization
Prof. Ingolf Cascorbi, Kiel University, President of International Union of Basic and Clinical Pharmacology (IUPHAR)

►Neuropsychopharmacology 1

The legacy of Arvid Carlsson: the past, present and future of psychopharmacology
Prof. Elias Eriksson, University of Gothenburg

Pharmacological application of growth factors
Prof. Raimo Tuominen, University of Helsinki

The potential of neuropeptides in psychopharmacology - insights from animal models
Prof. David J. Slattery, Johann Wolfgang Goethe-Universität Frankfurt am Main

Personalized psychopharmacology through animal models
Prof. Jaanus Harro, University of Tartu and North Estonia Medical Centre

TBC
Prof. Mart Saarma, University of Helsinki

►Recent Advancements in Drug Design and Delivery

Nanocrystal based formulations in drug delivery
Prof. Leena Peltonen, University of Helsinki

Finding new RNA targeting drug molecules
Prof. Mati Karelson, University of Tartu

Peptide-based drug delivery systems: preclinical development and applications in biotechnology
Dr Kaido Kurrikoff, University of Tartu  

Preclinical and clinical development of vascular homing peptides for precision medicine
Prof. Tambet Teesalu, University of Tartu

►Oncology

PGx of TKI resistance
Prof. Ingolf Cascorbi, Kiel University, President of International Union of Basic and Clinical Pharmacology (IUPHAR)

Current and future drugs in immunotherapy
Prof. Pärt Peterson, University of Tartu

Endocrine side effects of new oncological drugs
Prof. Vallo Volke, University of Tartu

Latest developments in pharmacotherapy of cancer
Dr Kersti Oselin, North Estonia Medical Centre

New developments in immunotherapy 
TBC

Early phase clinical trials
TBC

►Network for European Clinical Trials for Children

From microsampling to miniature mass spectrometers - advances in bioanalysis with limited sample volume
Dr Karin Kipper, Epilepsy Society, Head of Therapeutic Drug Monitoring Unit, the UK

The effects of augmented renal clearance on the pharmacokinetic profile of antibiotics
Dr Lenne-Triin Kõrgvee, Tartu University Hospital, University of Tartu

Measurement of glomerular filtration rate using iohexol
Dr Hiie Soeorg, University of Copenhagen

Vancomycin and DosOpt 
Dr Riste Kalamees, Tartu University Hospital, University of Tartu

Pharmacokinetics  of spironolactone in children under 2 years
Dr Jana Lass, Tartu University Hospital, University of Tartu 

Pharmacokinetics and concentration related effects of dobutamine in neonates
Dr Maarja Hallik, East Tallinn Central Hospital

15.00

►Emerging drugs in Endocrinology and Diabetes

Acute and Chronic Metabolic effects of Melatonin
Prof. Ulla Kampmann Opstrup, Steno Diabetes Center Aarhus and Aarhus University

Citrulline - more than just an amino acid
Prof. Alastair Forbes, Norwich Medical School, University of East Angla, the UK and University of Tartu

Long-acting amylin analogue: effects on weight and glycaemia
Dr Kirsten Raun, Scientific director, NovoNordisk

Secrets of GLP-1 receptor agonists
Prof. Vallo Volke, University of Tartu

New drugs for osteoporosis
Prof. Ugis Gruntmanis, Geisel School of Medicine at Dartmouth, USA

Short communications
TBC

Saturday, 11 September

University of Tartu main building

8.20 - 8.50

►Plenary lecture

Pharmacovigilance: from reactive to proactive and predictive
Prof. Lembit Rägo, Secretary-General of Council for International Organizations of Medical Sciences (CIOMS)

►Plenary lecture

Can dysregulated myelination be linked to ADHD pathogenesis and does this generate new treatment targets?
Prof. Klaus-Peter Lesch, University Hospital of Würzburg

►Neuropsychopharmacology 2

TBC
Prof. Edwin Zvartau, First Saint Petersburg State Pavlov Medical University

TBC
Dr Ilja Sukhanov, First Saint Petersburg State Pavlov Medical University

Epigenetics and Psychostimulant Addiction
Prof. Anti Kalda, University of Tartu

Extended release naltrexone for opioid use disorders: Advantages and problems
Prof. Evgeny Krupitsky, First Saint Petersburg State Pavlov Medical University

Neuronal plasticity and neurotrophin signaling in the antidepressant effect
Prof. Eero Castrén, University of Helsinki

►New drugs in Cardiology

How to combine antiplatelet and anticoagulant drugs?
Dr. Alar Irs, Tartu University Hospital and Estonian State Agency of Medicines

How to minimize the risk of arrhythmia with QT-prolonging drugs?
Dr. Jessica Schubert, Uppsala University Hospital

New drugs for treating dyslipidemia
Dr. Martin Serg, North Estonia Medical Centre

E-solutions to detect drug- drug interactions
TBC

►Closing remarks